Top Markets
Coin of the day
China Medicine Corp. China Medicine Corp.

China Medicine Corp.

CHME
Rangering i aksjer #38472
China Medicine Corporation produces and distributes prescription and over the... China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Aksjekurs
$0.0406
Sist synkronisert: 2026-08-13
Markedsverdi
$962.71K
Endring (1 dag)
0.00%
Endring (1 år)
6,666.67%
Land
CN
Handel China Medicine Corp. (CHME)

Kategori

P/B-forhold for China Medicine Corp. (CHME)
P/B-forhold per 2026 TTM: 0
Ifølge China Medicine Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for China Medicine Corp. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter